Nuclear imaging and therapy in oncology in Poland in 2021-2022
- PMID: 37037930
- PMCID: PMC10088604
- DOI: 10.1007/s00259-023-06216-1
Nuclear imaging and therapy in oncology in Poland in 2021-2022
Conflict of interest statement
JK reports unrestricted grant from Janssen, consulting fees from Telix and Novartis, LK consulting fees from Bayer. The remaining authors have no relevant conflict of interest to declare with regard to this comment.
References
-
- Eurostat, Physicians, by speciality, 2020 Health20 (2020).
-
- Enquête nationale annuelle. Société Française de Médecine Nucléaire et Imagerie Moléculaire. 2022. 230324-ENQUETE_2023(2022)_FINAL (cnp-mn.fr). Accessed 20 Mar 2023.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
